BioPorto Diagnostics

Denmark
Copenhagen, Capital Region, Denmark
+45 45 29 00 00 ★

Company profile

BioPorto Diagnostics company profile

BioPorto Diagnostics A/S is an in-vitro diagnostics company that provides healthcare professionals in clinical and research settings with a range of diagnostic tests and antibodies. Their pioneering product portfolio includes assays for underserved disease states, such as NGAL for acute kidney injury. They sell their products in more than 80 countries through diverse sales channels and partners. BioPorto has its headquarters in Copenhagen, Denmark and is listed on the Nasdaq Copenhagen stock exchange.

Business identity

Contact email
[email protected]
Phone number
+45 45 29 00 00
Operating status
Active
Company type
For Profit
Employee range
00011-00050 employees
Revenue range
$1K+
Founded
1995-01-01

Headquarters

Headquarters
Copenhagen, Capital Region, Denmark
Postal code
2900
Country code
DK
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Ipo
Funding rounds
4
Total equity funding
$23.6M
Last funding
Post Ipo Equity / $6.7M / 2025-11-13
Last equity funding
Post Ipo Equity / $6.7M
Articles
24
Exited on
2000-01-13

Founders and investors

No public relation records are available.

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.